Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.84 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.84 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.84 |
| ▸ | TSHR | P16473 | 4/20 | 0.84 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.84 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.84 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.63 |
| ▸ | MEN1 | O00255 | 5/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.63 |
| ▸ | HPGD | P15428 | 5/20 | 0.63 |
| ▸ | MAOA | P21397 | 3/20 | 0.58 |
| ▸ | NPC1 | O15118 | 3/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.52 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL380906 | 0.92 | KDM4E (1.00) | KDM4ECYP3A4HSD17B10TSHRCYP2C9 | |
| SCHEMBL4649956 | 0.89 | KDM4E (0.80) | KDM4ECYP3A4HSD17B10TSHRCYP2C9 | |
| SCHEMBL774316 | 0.89 | KDM4E (0.75) | KDM4ECYP3A4HSD17B10TSHRCYP2C9 | |
| SCHEMBL5796787 | 0.84 | KDM4E (0.65) | KDM4ECYP3A4HSD17B10TSHRCYP2C9 | |
| SCHEMBL23883097 | 0.83 | CYP2C9 (0.63) | KDM4ECYP3A4HSD17B10TSHRCYP2C9 | |
| SCHEMBL8854752 | 0.82 | KDM4E (0.72) | KDM4ECYP3A4HSD17B10TSHRCYP2C9 | |
| SCHEMBL29727380 | 0.82 | KDM4E (0.72) | KDM4ECYP3A4HSD17B10TSHRCYP2C9 | |
| SCHEMBL253523 | 0.79 | ABCG2 (1.00) | KDM4ECYP3A4HSD17B10TSHRCYP2C9 | |
| SCHEMBL29993383 | 0.79 | ABCG2 (1.00) | KDM4ECYP3A4HSD17B10TSHRCYP2C9 | |
| SCHEMBL9527476 | 0.79 | KDM4E (0.76) | KDM4ECYP3A4HSD17B10TSHRCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117561081-A | Application of CYP450 inhibitor in inhibiting or killing mites and treating xerophthalmia | 广州珍实视界生物医药科技有限公司 | 2024-02-13 | — | — | CN | claimed |
| EP-4258899-A1 | HYDROXY- AND METHOXY-SUBSTITUTED FLAVONES AND THEIR USE | Firmenich SA (CH) | 2023-10-18 | — | — | EP | claimed |
| CN-116249520-A | Blocking replication of SARS-COV-2 and other pathogenic viruses using WNT/beta-catenin pathway inhibitors | 阿尔伯塔大学理事会 | 2023-06-09 | — | — | CN | claimed |
| WO-2022189155-A1 | HYDROXY- AND METHOXY-SUBSTITUTED FLAVONES AND THEIR USE | FIRMENICH SA (CH) | 2022-09-15 | — | — | WO | claimed |
| CN-114867486-A | Composition containing Heijiang extract and oral composition | 丸善制药株式会社 | 2022-08-05 | — | — | CN | claimed |
| WO-2021050449-A1 | COMPOSITIONS AND METHODS OF SUPPRESSING AVERSIVENESS OF PHARMACEUTICALS AND INGESTIBLE MATERIALS | MONELL CHEMICAL SENSES CENTER (US) | 2021-03-18 | — | — | WO | claimed |
| CN-106455665-B | Black ginger oil extract and preparation method thereof | 三得利控股株式会社 | 2020-06-30 | — | — | CN | claimed |
| CN-107411083-A | Cape jasmine alcohol elution auxiliary improvement of memory capsule or tablet are applied in auxiliary improving memory function health food is prepared | 江西中医药大学 | 2017-12-01 | — | — | CN | claimed |
| CN-106619674-A | Application of effective part or effective component of jasmines in preparation of medicine or health-care food for treating heterogeneitys and multi-factors' alzheimer's diseases | 张忠立 | 2017-05-10 | — | — | CN | claimed |
| CN-102018740-B | Pharmaceutical composition containing sunflower leaf extract and use thereof | PEIXUE LING | 2012-05-23 | — | — | CN | claimed |
| EP-1807408-A1 | OXY SUBSTITUTED FLAVONES AS ANTIHYPERGLYCEMIC AND ANTIDYSLIPIDEMIC AGENTS | Council of Scientific and Industrial Research (IN) | 2007-07-18 | — | — | EP | claimed |
| WO-2006040621-A1 | OXY SUBSTITUTED FLAVONES AS ANTIHYPERGLYCEMIC AND ANTIDYSLIPIDEMIC AGENTS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2006-04-20 | — | — | WO | claimed |
| US-20250281559-A1 | DRUG FOR TREATMENT OF BREAST CANCER WITH ANTLER AND GINSENG AS SOVEREIGN DRUG AND PREPARATION METHOD AND APPLICATION THEREOF | JILIN UNIVERSITY (CN) | 2025-09-11 | — | — | US | disclosed |
| US-20250263774-A1 | DISCOVERING NEW XENOBIOTIC SUBSTRATES OF AN UDP-GLYCOSYLTRANSFERASE WITH A HIGH-THROUGHPUT METHOD | UNIV NORTH TEXAS (US) | 2025-08-21 | — | — | US | disclosed |
| US-20240389587-A1 | COMPOSITIONS AND METHODS FOR CONTROLLING PHYTOPATHOGENIC INFECTIONS | INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT (INRAE) (FR) | 2024-11-28 | — | — | US | disclosed |
| US-20240197890-A1 | FLAVONE DERIVATIVES AND USES IN TARGETING CK2-MEDIATED DISEASES AND CONDITIONS | SALK INSTITUTE FOR BIOLOGICAL STUDIES | 2024-06-20 | — | — | US | disclosed |
| WO-2011157936-A1 | COMPOSITIONS CONTAINING FLAVONES AND ANTHELMINTICS | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 2011-12-22 | — | — | WO | disclosed |
| US-20110177237-A1 | ANTIFOULING METHOD AND COMPOSITION USING CHROMEN-4-ONE DERIVATIVES | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2011-07-21 | — | — | US | disclosed |
| US-20110124721-A1 | METHODS OF TREATING TRAUMATIC BRAIN INJURY BY ADMINISTERING BAICALEIN PREPARATION | NATIONAL DEFENSE MEDICAL CENTER (TW) | 2011-05-26 | — | — | US | disclosed |
| US-20100222421-A1 | Usage of Baicalein in the Preparation of a Pharmaceutical Composition for the Treatment of Traumatic Brain Injury | NATIONAL DEFENSE MEDICAL CENTER (TW) | 2010-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240389587-A1 | COMPOSITIONS AND METHODS FOR CONTROLLING PHYTOPATHOGENIC INFECTIONS | XBP1, ERN1, ERN2 | KDM4E 2982/4885CYP3A4 2585/4885HSD17B10 1357/4885 |
| US-20240197890-A1 | FLAVONE DERIVATIVES AND USES IN TARGETING CK2-MEDIATED DISEASES AND CONDITIONS | PACSIN2, CSNK1E, CSNK2A2 | KDM4E 2594/4885CYP3A4 2817/4885HSD17B10 2863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.